{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:11:51Z","timestamp":1793121111384,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.intimp.2023.109680","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T18:04:18Z","timestamp":1675447458000},"page":"109680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model"],"prefix":"10.1016","volume":"116","author":[{"given":"Jianfeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peida","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2023.109680_b0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0974-620X.116624","article-title":"Ocular chemical injuries and their management","volume":"6","author":"Singh","year":"2013","journal-title":"Oman J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109680_b0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jtos.2016.09.002","article-title":"Current and Upcoming Therapies for Ocular Surface Chemical Injuries","volume":"15","author":"Baradaran-Rafii","year":"2017","journal-title":"Ocul. Surf."},{"issue":"2","key":"10.1016\/j.intimp.2023.109680_b0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.survophthal.2017.09.005","article-title":"Treatment of acute ocular chemical burns","volume":"63","author":"Sharma","year":"2018","journal-title":"Surv. Ophthalmol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109680_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/iovs.63.4.14","article-title":"Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats","volume":"63","author":"Lan","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2023.109680_b0025","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1076\/ceyr.16.7.670.5057","article-title":"Cytokine expression in the alkali-burned cornea","volume":"16","author":"Sotozono","year":"1997","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.intimp.2023.109680_b0030","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.2147\/DDDT.S175297","article-title":"The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor","volume":"12","author":"Chen","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2023.109680_b0035","doi-asserted-by":"crossref","first-page":"1106313","DOI":"10.1155\/2022\/1106313","article-title":"Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages","volume":"2022","author":"Feng","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"47","key":"10.1016\/j.intimp.2023.109680_b0040","doi-asserted-by":"crossref","first-page":"23705","DOI":"10.1073\/pnas.1908355116","article-title":"RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularization","volume":"116","author":"Ueta","year":"2019","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.intimp.2023.109680_b0045","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/ICO.0b013e31823f8b40","article-title":"Activated macrophages induce neovascularization through upregulation of MMP-9 and VEGF in rat corneas","volume":"31","author":"Li","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.intimp.2023.109680_b0050","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.2147\/IJN.S117425","article-title":"Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats","volume":"11","author":"Li","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.intimp.2023.109680_b0055","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109680_b0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2023.109680_b0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/02713683.2016.1196705","article-title":"Interleukin (IL)-17A Promotes Angiogenesis in an Experimental Corneal Neovascularization Model","volume":"42","author":"Liu","year":"2017","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.intimp.2023.109680_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.intimp.2023.109680_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.716672","article-title":"Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway","volume":"12","author":"Yin","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2023.109680_b0080","first-page":"ii3-ii10","article-title":"JAK1: Number one in the family; number one in inflammation","volume":"60","author":"Spinelli","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.intimp.2023.109680_b0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109680_b0090","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ibd\/izy364","article-title":"A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function","volume":"25","author":"De Vries","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.intimp.2023.109680_b0095","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40257-020-00548-6","article-title":"Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib","volume":"21","author":"Ferreira","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.intimp.2023.109680_b0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s41927-018-0031-x","article-title":"In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)","volume":"2","author":"Parmentier","year":"2018","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.intimp.2023.109680_b0110","article-title":"Laquinimod Inhibits Inflammation-Induced Angiogenesis in the Cornea","volume":"7","author":"Li","year":"2020","journal-title":"Front. Med. (Lausanne)."},{"issue":"8","key":"10.1016\/j.intimp.2023.109680_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082208","article-title":"Chemopreventive Effects of Phytochemicals and Medicines on M1\/M2 Polarized Macrophage Role in Inflammation-Related Diseases","volume":"19","author":"Koh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2023.109680_b0120","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41433-019-0456-5","article-title":"An update on chemical eye burns","volume":"33","author":"Bizrah","year":"2019","journal-title":"Eye (Lond.)"},{"issue":"6","key":"10.1016\/j.intimp.2023.109680_b0125","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ajpath.2017.02.005","article-title":"Mechanisms of Retinal Damage after Ocular Alkali Burns","volume":"187","author":"Paschalis","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.intimp.2023.109680_b0130","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1080\/02713683.2017.1317817","article-title":"Comprehensive Modeling of Corneal Alkali Injury in the Rat Eye","volume":"42","author":"Choi","year":"2017","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.intimp.2023.109680_b0135","first-page":"2135","article-title":"An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model","volume":"19","author":"Uchiyama","year":"2013","journal-title":"Mol. Vis."},{"issue":"10","key":"10.1016\/j.intimp.2023.109680_b0140","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1167\/iovs.08-2805","article-title":"Bevacizumab application delays epithelial healing in rabbit cornea","volume":"50","author":"Kim","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2023.109680_b0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond.)"},{"issue":"2","key":"10.1016\/j.intimp.2023.109680_b0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.ico.0000248385.16896.34","article-title":"Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration","volume":"26","author":"Lu","year":"2007","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.intimp.2023.109680_b0155","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.109680_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.667830","article-title":"Macrophage-Mediated Tissue Vascularization: Similarities and Differences Between Cornea and Skin","volume":"12","author":"Hadrian","year":"2021","journal-title":"Front. Immunol."},{"issue":"443","key":"10.1016\/j.intimp.2023.109680_b0165","doi-asserted-by":"crossref","first-page":"ra86","DOI":"10.1126\/scisignal.aaf3596","article-title":"Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages","volume":"9","author":"Piccinini","year":"2016","journal-title":"Sci. Signal."},{"issue":"15","key":"10.1016\/j.intimp.2023.109680_b0170","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.biomaterials.2014.02.012","article-title":"The role of macrophage phenotype in vascularization of tissue engineering scaffolds","volume":"35","author":"Spiller","year":"2014","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.intimp.2023.109680_b0175","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/imm.12571","article-title":"Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization","volume":"147","author":"Zhu","year":"2016","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.intimp.2023.109680_b0180","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/blood-2007-08-108597","article-title":"TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype","volume":"111","author":"Sainson","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.intimp.2023.109680_b0185","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2009-12-257832","article-title":"Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction","volume":"116","author":"Fantin","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.intimp.2023.109680_b0190","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2353\/ajpath.2007.061018","article-title":"Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization","volume":"170","author":"Izumi-Nagai","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.intimp.2023.109680_b0195","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1167\/iovs.08-2732","article-title":"Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist","volume":"50","author":"Lu","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.109680_b0200","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/stem.2781","article-title":"Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function","volume":"36","author":"Eslani","year":"2018","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.intimp.2023.109680_b0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.advms.2015.10.003","article-title":"Assessment of therapeutic options for reducing alkali burn-induced corneal neovascularization and inflammation","volume":"61","author":"Bakunowicz-\u0141azarczyk","year":"2016","journal-title":"Adv. Med. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.109680_b0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/1744666X.2022.2042254","article-title":"Affecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritis","volume":"18","author":"Garufi","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109680_b0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","article-title":"Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo","volume":"17","author":"Jetten","year":"2014","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.intimp.2023.109680_b0220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","article-title":"Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing","volume":"82","author":"Gan","year":"2004","journal-title":"Acta Ophthalmol. Scand."},{"issue":"5","key":"10.1016\/j.intimp.2023.109680_b0225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/02713681003597230","article-title":"A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization","volume":"35","author":"Zuo","year":"2010","journal-title":"Curr. Eye Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.109680_b0230","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1167\/iovs.11-9139","article-title":"Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization","volume":"53","author":"Qazi","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.109680_b0235","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T08:07:21Z","timestamp":1719216441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":46,"alternative-id":["S1567576923000036"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109680","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109680"}}